Medical devices and interventions, have been developed specifically for low-resource settings, and aim to be of low cost, easy to use, and culturally appropriate. But these devices commonly fail to reach scale of production and implementation in their intended markets. Some international organisations have emphasised the ability of global health technologies to support universal health coverage.The difficult last mile translation (eg, the final phase when the product is finally delivered to patients and providers) for existing, highly effective medical devices has to first be addressed to improve health-care in low-resource settings.

More Syed Amin Tabish's questions See All
Similar questions and discussions